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Abstract
Stressful and aversive events promote maladaptive reward‐seeking behaviors such as drug addiction by acting,
in part, on the mesolimbic dopamine system. Using animal models, data from our laboratory and others show
that stress and cocaine can interact to produce a synergistic effect on reward circuitry. This effect is also
observed when the stress hormone corticosterone is administered directly into the nucleus accumbens (NAc),
indicating that glucocorticoids act locally in dopamine terminal regions to enhance cocaine's effects on
dopamine signaling. However, prior studies in behaving animals have not provided mechanistic insight. Using
fast‐scan cyclic voltammetry, we examined the effect of systemic corticosterone on spontaneous dopamine
release events (transients) in the NAc core and shell in behaving rats. A physiologically relevant systemic
injection of corticosterone (2 mg/kg i.p.) induced an increase in dopamine transient amplitude and duration
(both voltammetric measures sensitive to decreases in dopamine clearance), but had no effect on the frequency
of transient release events. This effect was compounded by cocaine (2.5 mg/kg i.p.). However, a second
experiment indicated that the same injection of corticosterone had no detectable effect on the dopaminergic
encoding of a palatable natural reward (saccharin). Taken together, these results suggest that corticosterone
interferes with naturally occurring dopamine uptake locally, and this effect is a critical determinant of dopamine
concentration specifically in situations in which the dopamine transporter is pharmacologically blocked by
cocaine.
We examined the effect of corticosterone on spontaneous dopamine release events (transients) in the NAc core
and shell in behaving rats. Corticosterone increased dopamine transient amplitude and duration (measures
sensitive to decreases in dopamine clearance), but had no effect on the frequency of transient release events.
This effect was compounded by cocaine. These results suggest that corticosterone acts synergistically with
cocaine to interfere with naturally occurring dopamine uptake.
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People vulnerable to bouts of drug abuse or overeating report that stressful life events can precipitate these
maladaptive behaviors (Hyman et al., [ 26] ; Dallman, [ 13] ). Preclinical studies model this impact of stress,
showing that noxious stimulation, and the glucocorticoid response that it engenders, can enhance acquisition,
escalation, and reinstatement of drug seeking (see Mantsch et al., [ 33] for review). The glucocorticoid hormone
corticosterone is required for the acute psychomotor stimulant effects of cocaine (Marinelli et al., [ 34] ,[ 35] );
facilitates the acquisition of cocaine self‐administration (Goeders & Guerin, [ 19] ,[ 20] ); and is required for the

escalation of cocaine intake under conditions of extended access to the drug (Mantsch & Katz, [ 32] ). Stress‐
induced reinstatement of extinguished drug‐seeking behavior requires corticosterone (Erb et al., [ 16] ; Mantsch
& Goeders, [ 31] ), although elevations in the hormone alone may not be sufficient to cause reinstatement (Lee
et al., [ 28] ; Graf et al., [ 21] ; but see Deroche et al., [15] ). Previous studies indicate that the impact of stress on
drug‐seeking behavior is, in part, due to the effects of corticosterone on dopamine (DA) signaling in reward‐
processing circuitry. Specifically, corticosterone augments cocaine's ability to increase DA concentration in the
nucleus accumbens (NAc), potentiating cocaine‐induced locomotor activity and cocaine‐induced reinstatement
of drug seeking (Rouge‐Pont et al., [ 43] ; Graf et al., [ 21] ). In our studies, corticosterone potentiated cocaine‐
primed reinstatement both when the steroid was administered systemically and when it was directly infused
into the NAc, demonstrating that corticosterone acts locally in the NAc to modulate drug seeking behavior (Graf
et al., [ 21] ).
In addition to its effects on cocaine seeking, stress also influences the processing of natural rewards, potentially
through similar physiological pathways (Reynolds & Berridge, [ 41] ; Volkow et al., [ 54] ; Berridge, [ 4] ). Stress
can cause overeating, particularly of palatable foods, in both laboratory animals and overweight people
(Rowland & Antelman, [ 44] ; Dallman, [ 13] ). As with cocaine, behavioral and dopaminergic responses to
natural rewards are modulated by glucocorticoids. Adrenalectomized rats exhibit reduced consumption of
natural gustatory rewards, and regular levels of consumption are restored by corticosterone supplement (Bell
et al., [ 3] ; Bhatnagar et al., [ 6] ). Furthermore, exogenous glucocorticoid administration causes overeating and
weight gain (Tataranni et al., [ 50] ). The influence of corticosterone on natural reward processing likely co‐
occurs with an increase in DA levels in the NAc in response to palatable foods. Corticosterone facilitates DA
signaling in the NAc (Barrot et al., [ 2] ), and rats will readily self‐administer corticosterone itself, the
consumption of which increases DA, particularly during feeding (Piazza et al., [ 39] ).
The notion that stress and glucocorticoids may contribute to both obesity and addiction through a common
dopaminergic mechanism is intriguing (Volkow et al., [ 54] ). Using fast‐scan cyclic voltammetry in behaving rats,
we examined the effects of corticosterone on subsecond DA signaling in the NAc to determine: (i) the specific
components of spontaneous DA signals altered by corticosterone alone, (ii) the effects of corticosterone on DA
signaling after cocaine administration, and (iii) the effects of corticosterone on DA signals in response to a
natural reward. Scrutinizing individual characteristics of spontaneous dopamine release events (i.e. transients)
can reveal a selective influence on extracellular DA signaling, and potentially suggest corticosterone's
mechanism of action. The frequency of observed transients reflects DA release frequency, a factor that is
dictated by the burst firing of DA neurons. Peak transient amplitude is sensitive to factors that influence both
release and clearance, and transient duration (as measured by half‐width) is affected by changes in DA clearance
(Wightman et al., [ 58] ; Cragg & Rice, [ 12] ; Aragona et al., [ 1] ). For example, several reinforcing drugs (e.g.
nicotine, ethanol, and cocaine) increase dopamine concentration, but of these, only cocaine increases transient
duration, indicative of its actions blocking the dopamine transporter (Cheer et al., [ 8] ). The following findings
indicate that corticosterone preferentially affects DA uptake and is more influential in situations in which the DA
transporter is blocked by cocaine.

Methods
Subjects

Male Sprague–Dawley rats (Envigo) weighing 275–300 g were individually housed in a temperature and humidity
controlled AAALAC‐accredited vivarium. Rats were maintained on a 12/12 reversed dark/light cycle, and all
experimental procedures were conducted during the dark phase (starting at 0700 hours) to more closely
approximate the procedures of Graf et al. ([ 21] ). All experimental protocols were approved by the Institutional
Animal Care and Use Committee at Marquette University in accordance with the National Institutes of Health

Guide for the Care and Use of Laboratory Animals. Seventeen (10 corticosterone and seven vehicle treated) rats
were used in the cocaine experiment, and five naïve rats were used in the saccharin experiment.

Surgical procedures

All surgical procedures were conducted under ketamine/xylazine (100 mg/kg; 20 mg/kg, i.p.) anesthesia. A 1‐mm
diameter electrode guide cannula (BASi) was implanted above the NAc core (AP: +1.3; ML: ± 1.3) or NAc shell
(AP: +1.7; ML: ± 0.8) unilaterally, and a Ag/AgCl reference electrode was placed contralateral to the guide
cannula. For the saccharin experiment, a single intraoral catheter was implanted as previously described
(Wheeler et al., [ 55] ). For all surgical procedures, rats were treated with the anti‐inflammatory meloxicam (1%
oral suspension) the day of, and for 4 days following surgery to reduce inflammation and postoperative pain.

Apparatus

Both experiments were conducted in a standard operant chamber (Med Associates), interfaced with a
computer, and housed in sound attenuating Faraday cages. The operant chamber had a dedicated syringe pump
for intraoral infusions of saccharin sodium salt (0.15% based on the weight of the salt; Sigma) that were
delivered to each rat via a single‐channel fluid swivel (Instech Laboratories). The chamber floor was clear acrylic
glass, and illumination was provided by a house light positioned on the door of the sound‐attenuating chamber.
Rats were harnessed to a rotating commutator (Crist Instruments) for electrochemical recordings.
Corticosterone (1 mg/mL; Sigma) was dissolved in a 90% saline and 10% ethanol vehicle solution (Spencer &
Deak, [ 48] ). Cocaine HCl (NIDA; 8.25 mg/mL based on the weight of the salt) was dissolved in a saline vehicle.

Cocaine experiment

On a day prior to DA measurements, subjects were habituated to the recording environment for approximately
1 h. The experiment consisted of DA measurements during a 30‐min baseline phase, a 40‐min corticosterone or
vehicle phase, and a 40‐min cocaine phase (see Fig. [NaN] ). Corticosterone (2.0 mg/kg i.p.) and cocaine
(2.5 mg/kg i.p.) were administered immediately before their respective recording phases. This dose of
corticosterone produces a plasma corticosterone level similar to that produced by an acute stressor (Graf et al.,
[ 21] ). The low dose of cocaine was specifically chosen because it does not produce reinstatement of cocaine
seeking when administered alone, but does cause reinstatement when administered with corticosterone (Graf
et al., [ 21] ). Before each experiment, a carbon fiber electrode was lowered into the NAc. The fiber was held at
−0.4 V between scans and then driven to +1.3 V and back in a triangular fashion at 400 V/s for each
voltammetric measurement. The application of this triangle waveform causes oxidation and reduction in
chemical species that are electroactive within this potential range, producing a change in current at the carbon‐
fiber. Specific analytes (including DA and pH) are identified by plotting these changes in current against the
applied potential to produce a cyclic voltammogram (Heien et al., [ 22] , [ 23] ). The current arising from
electrode processes was removed using background subtraction. Recordings were blocked into 30‐s bins, and
the background period was taken as the nadir during each bin. This practice does not subtract the presence of
spontaneous DA release events because the background was explicitly selected for the absence of DA signals.
Measurements were made every 100 ms and, after driving the electrode into the NAc, the electrode
equilibrated for 40 min before any data were collected. Because the present experiment required an analysis of
naturally occurring DA signaling, the dorsoventral position of the microelectrode was optimized by monitoring
the presence of spontaneously occurring DA release events (Wightman et al., [ 59] ; Roitman et al., [ 42] ;
Wheeler et al., [ 56] ; Twining et al., [ 51] ). Once this was observed, the electrode was locked in place and data
collection proceeded.
Analyte identification and quantification were achieved using a principal component regression analysis
described in detail elsewhere (Heien et al., [ 22] ). All data presented here fit the resulting model at the 95%
confidence level. Briefly, training sets were generated from background‐subtracted cyclic voltammograms

collected during and after electrical stimulations. DA was isolated with a chemometric analysis using a previously
recorded training set (Twining et al., [ 51] ; Wheeler et al., [ 57] ) matched for oxidation potential and transient
amplitude. The resulting current amplitude was converted to DA concentration based on the average post‐
experiment electrode sensitivity (Wheeler et al., [ 57] ). Transient analysis was adapted from Vander Weele et al.
([ 53] ). Transients were identified with MATLAB (code provided by Dr. Richard Keithley) and characterized with
Mini Analysis (Synaptosoft). Transients were defined as DA fluctuations that exceeded 20 nm, lasted at least
200 ms, and were at least five times greater than the root‐mean‐square noise sampled during a 2‐s period in
each trial.

Saccharin experiment

Because the DA response to saccharin is variable between subjects and brief relative to the effects of cocaine, a
purely within‐subjects design was employed to maximize sensitivity to any potential effect of corticosterone.
Furthermore, all recordings were made in the NAc shell because DA signaling in this subregion is more sensitive
to primary rewarding or aversive stimuli (Wheeler et al., [ 56] ). On a day prior to DA measurements, subjects
were habituated to the recording environment for approximately 1 h. During the habituation session, all
subjects received 30 intraoral infusions of a 0.15% saccharin solution (0.2 mL over 15 s) to reduce any neophobia
during the experiment. The experiment consisted of DA measurements during a 30‐min pre‐corticosterone
saccharin phase, a 40‐min corticosterone phase, and a 30‐min post‐corticosterone saccharin phase (see
Fig. [NaN] A). Subjects received 30 intraoral infusions during each saccharin phase. DA measurements were
acquired and isolated as in the cocaine experiment. In order to assess the phasic response to saccharin before
and after corticosterone administration, each trial was divided into a 10‐s pre‐infusion baseline epoch and a 20‐s
infusion epoch. Background was subtracted from the nadir during the baseline epoch. After conducting
chemometric analyses, the average DA concentrations during the two epochs were compared.

Histology

After the completion of each experiment, subjects were euthanized with CO2 according to Institutional Animal
Care and Use Committee guidelines. To verify placements of voltammetry recordings, small electrolytic lesions
were created by running a current (250 μA) through a stainless steel electrode placed at the depth at which the
recording took place. Brains were then removed and submerged in 10% formaldehyde for 14 days. All brains
were then sliced into 40‐μm sections, mounted, stained with 0.25% thionin, and coverslipped.

Statistical analysis

In the cocaine experiment, time‐averaged DA concentrations, transient frequency, half‐width, and amplitude
were analyzed with four separate 2 (group: corticosterone vs. vehicle) × 3 (phase: baseline vs. treatment vs.
cocaine) mixed anovas followed by planned contrasts to determine whether DA is elevated during the treatment
phase (relative to baseline) and again during the cocaine phase (relative to the treatment phase). In the
saccharin experiment, time‐averaged DA concentrations were analyzed with a 2 (epoch: baseline vs. infusion) ×
2 (phase: pre‐ vs. post‐corticosterone) within‐subjects anova. Statistical analyses were performed using
Statistica 6.0 (Stat Soft).

Results
Corticosterone and cocaine interacted to increase extracellular DA in the NAc

In the first experiment, potential interactions between cocaine and corticosterone in the regulation of overall
DA concentration were assessed in the NAc core and shell. Figure [NaN] depicts the experimental design and
time‐averaged DA concentration (average color plots) from representative corticosterone‐ and vehicle‐treated
rats across the three experimental phases. A comparison of core (n = 4) and shell (n = 6) electrode placements in
corticosterone‐treated rats showed an effect of phase, F2,16 = 23.54, P < 0.001, but no effect of placement,

F1,8 = 0.44, P = 0.53, and no placement × phase interaction, F2,16 = 0.98, P = 0.40 (see Fig. [NaN] A). Therefore,
core and shell data were collapsed in subsequent analyses. Corticosterone appeared to cause an elevation in
average DA concentration, and only corticosterone‐treated rats exhibited an increase in DA concentration after
the injection of cocaine (see Fig. [NaN] B). anova revealed an effect of phase, F2,30 = 13.92, P < 0.001, and a group
× phase interaction, F2,30 = 12.62, P < 0.001, but no effect of group, F1,15 = 1.15, P = 0.30. Planned contrasts
showed that corticosterone elevated DA above baseline levels, F1,15 = 9.95, P < 0.007, and cocaine further
elevated DA above the level observed with corticosterone alone, F1,15 = 33.82, P < 0.001. Vehicle injections
produced no elevation of DA above baseline, F1,15 = 3.03, P = 0.10, and cocaine alone produced no elevation
relative to the vehicle phase, F1,15 = 0.91, P = 0.36. Although the latter null result may seem counterintuitive, the
low dose of cocaine administered here does not facilitate reinstatement of cocaine seeking and does not
increase DA as measured by microdialysis (Graf et al., [ 21] ). Figure [NaN] C depicts electrode placements for
the corticosterone and vehicle groups.

Corticosterone selectively affected measures of DA uptake

Next, the characteristics of spontaneous DA transient release events were scrutinized to determine whether
corticosterone preferentially affected release or uptake. Figure [NaN] A depicts the measured characteristics of
transient DA release events. Transient frequency is primarily an indicator of DA release, transient amplitude is
affected by both release and uptake, and half‐width is primarily influenced by uptake (Cragg & Rice, [ 12] ;
Aragona et al., [ 1] ; Vander Weele et al., [ 53] ). anovas were conducted to examine each characteristic. An
analysis of transient amplitude revealed an effect of phase, F2,30 = 8.94, P < 0.001, and a group × phase
interaction, F2,30 = 5.80, P < 0.008, but no effect of group, F1,15 = 2.43, P = 0.14 (see Fig. [NaN] B). Similar to the
pattern observed in the time‐averaged concentration data, transient amplitude was augmented by
corticosterone, F1,15 = 9.86, P < 0.007, and further elevated by cocaine, F1,15 = 11.51, P < 0.005. No similar effects
were observed in the vehicle condition, Fs < 3.6, Ps > 0.07. The analysis of transient half‐width showed an effect
of phase, F2,30 = 51.34, P < 0.001, and a group x phase interaction, F2,30 = 21.37, P < 0.001, but no effect of group,
F1,15 = 4.33, P > 0.054 (see Fig. [NaN] C). As with time‐averaged concentration and transient amplitude, transient
half‐width was increased by corticosterone, F1,15 = 24.75, P < 0.001, and further increased by cocaine
F1,15 = 68.39, P < 0.001. Vehicle produced no effect, F1,15 = 0.41, P = 0.53, but cocaine did have an effect on half‐
width after vehicle injection, F1,15 = 6.36, P < 0.03. This increase in half‐width seems to be relatively weak, as it is
not reflected in the time‐average DA concentration measurement. However, the corticosterone group exhibited
longer transients than the vehicle group during the cocaine phase, F1,15 = 17.72, P < 0.001, showing that
corticosterone potentiated the effect that cocaine normally has on half‐width. In contrast, the frequency of
transient release events was unaffected by corticosterone, vehicle, or cocaine, Fs < 2.68, Ps > 0.08 (see
Fig. [NaN] D), suggesting that DA neuron activity was not generally excited by administration of either
corticosterone or cocaine. Thus, corticosterone and cocaine selectively inflated measures that are sensitive to
reductions in DA clearance, but had no appreciable effect on the number of release events.

Corticosterone did not affect the DA response to gustatory rewards

Finally, because corticosterone alone had an effect on DA signaling, and because past microdialysis studies have
indicated that exogenous corticosterone increases DA levels in the NAc particularly during feeding (Piazza et al.,
[ 39] ), we examined the possibility that the steroid would modulate the DA response to saccharin, an appetitive
natural reward. Figure [NaN] A shows the timing of events for each rat in the saccharin experiment. An intraoral
saccharin infusion normally produces a phasic DA release in the NAc shell (see Fig. [NaN] B; Roitman et al., [ 42] ;
Wheeler et al., [ 56] , [ 57] ). Here, naturally rewarding saccharin produced a phasic increase in DA that was
unaffected by corticosterone administration (Fig. [NaN] C and D). anova revealed an effect of epoch, F1,4 = 14.84,
P < 0.02, but no other effect or interaction, Fs < 0.10, Ps > 0.77. Figure [NaN] E depicts the electrode placements
in the NAc shell.

Discussion
Microdialysis studies have demonstrated that stress and glucocorticoids can increase DA in the NAc and
augment the effect of cocaine on DA concentration, but mechanistic insight into how this occurs has been
lacking (Piazza et al., [ 39] ; Graf et al., [ 21] ). Using fast‐scan cyclic voltammetry in behaving rats, we found that
a physiologically relevant injection of corticosterone selectively increases the amplitude and duration of
spontaneous DA release events, and markedly augments cocaine's effect on those measures. These
observations provide unique insight into the mechanisms by which corticosterone and cocaine interact to
influence DA signaling during moment‐to‐moment behavior.

The effect of corticosterone on spontaneous DA signaling

There are at least two mechanisms by which corticosterone might enhance DA signaling in the NAc. First,
corticosterone can act in the ventral tegmental area (VTA) to increase the sensitivity of VTA neurons to
glutamatergic signaling. Specifically, corticosterone has been shown to lower NMDA excitatory thresholds in the
VTA (Berry et al., [ 5] ), and to augment spontaneous neural firing in the presence of AMPA or NMDA through a
non‐genomic mechanism under temporal parameters similar to those used in the present studies (Cho & Little,
[ 10] ). However, it is unlikely that an increase in glutamate sensitivity in DA neurons would selectively affect
transient amplitude and duration, but not frequency. In fact, NMDA in the VTA induces burst firing in DA
neurons (Chergui et al., [9] ), and NMDA receptor antagonism explicitly reduces transient frequency in the NAc
(Sombers et al., [ 46] ). Thus, although there may be situations in which corticosterone can alter glutamate
sensitivity in VTA neurons, it is unlikely that changes in DA neuron sensitivity to glutamate are responsible for
the results observed here.
Instead, the pattern of results suggests that corticosterone is acting locally in the NAc to interfere with DA
uptake mechanisms. We have previously demonstrated that corticosterone can potentiate cocaine‐primed
reinstatement of drug seeking even when infused directly into the NAc, supporting the hypothesis that it acts
locally in DA terminal regions to potentiate the effects of cocaine on DA (Graf et al., [ 21] ). One likely
mechanism of action is corticosterone's blockade of uptake2‐mediated DA clearance in the NAc (Iversen & Salt,
[ 27] ). Recent studies specifically implicate organic cation transporter 3 (OCT3), an uptake2 transporter inhibited
by corticosterone at physiological concentrations (Gasser et al., [17] ; Hill et al., [ 24] ), in the ability of stress and
corticosterone to potentiate cocaine‐primed reinstatement. These studies demonstrate: (i) that corticosterone
decreases DA transporter‐independent DA clearance in the NAc of anesthetized rats; and (ii) that mice
genetically engineered to lack OCT3‐mediated transport (Wultsch et al., [ 60] ) do not exhibit the corticosterone‐
induced potentiation of cocaine‐primed reinstatement that is observed in wild‐type mice (McReynolds et al.,
[ 37] ). Considering this convergent evidence, it is likely that the effects of corticosterone on DA transients
observed in the current studies are due to local actions of the hormone in the NAc to block OCT3‐mediated DA
clearance, resulting in prolonged DA transients that are further lengthened by cocaine's actions on the DA
transporter.

The effect of corticosterone and cocaine on spontaneous DA signaling

This is the first description of an interaction between corticosterone and cocaine in the regulation of subsecond
DA signaling in awake and behaving animals. Previous studies have reported that cocaine alone boosts transient
frequency, amplitude, and duration, particularly in the shell of the NAc (Stuber et al., [ 49] ; Aragona et al., [ 1] ).
Aragona et al. ([ 1] ) found that cocaine increased transient amplitude and half‐width equally in the core and
shell regions, but preferentially increased transient frequency in the shell subregion. This core/shell difference
could be facilitated by corticosterone, as microdialysis experiments have shown that cocaine‐induced DA
concentration increases in the shell, but not the core, require endogenous corticosterone (Barrot et al., [ 2] ). In
contrast, we found that a comparatively low dose of cocaine, when combined with corticosterone, increased

transient amplitude and half‐width in the core and shell regions, but did not affect frequency in either region. As
stated above, this suggests that the low dose of cocaine, combined with corticosterone, is not likely acting in the
VTA to increase DA neuron burst firing rates, but instead selectively regulating DA clearance. Based on the
previous findings, a larger dose of cocaine would almost certainly preferentially boost DA in the shell and
increase transient frequency either through a pre‐synaptic mechanism or through disinhibitory NAc feedback to
the VTA (Aragona et al., [ 1] ; Bocklisch et al., [ 7] ). Perhaps not coincidentally, sensitivity to the rewarding
effects of cocaine at higher doses is less affected by stress or the administration of exogenous corticosterone
(Goeders & Guerin, [ 18] ; Mantsch & Goeders, [ 30] ).

The effect of corticosterone on saccharin‐induced DA release

Although corticosterone had a clear synergistic relationship with cocaine, it had no effect on the DA response to
the natural gustatory reward, saccharin. This indicates that corticosterone can differentially affect the
processing of natural and drug rewards. This finding is somewhat surprising because stress and glucocorticoids
can increase the consumption of palatable foods (Rowland & Antelman, [ 44] ; Dallman et al., [ 14] ; Dallman,
[ 13] ), and previous studies have found that corticosterone facilitates consumption of and appetitive responses
to saccharin (Silva, [ 45] ; Bhatnagar et al., [ 6] ), which presumably would be reflected in DA signaling. However,
there are factors to consider that may explain why corticosterone selectively affected the DA response to
cocaine. In studies describing a reduction of saccharin consumption or palatability in adrenalectomized rats,
there is no evidence of enhanced saccharin consumption or palatability in situations in which corticosterone is
elevated above normal levels. That is, there may be a certain level of circulating corticosterone that is required
for normal saccharin palatability, but elevations beyond that threshold do not augment palatability. Additionally,
we are not aware of studies demonstrating that acute stress or glucocorticoid administration enhance the
palatability or consumption of saccharin in intact rats, and they may even decrease motivation to consume
saccharin (Plaznik et al., [ 40] ; Howell et al., [ 25] ). It is likely that DA signaling would be dramatically altered in
animals with low corticosterone levels, as DA flexibly tracks reward value (Wheeler et al., [56] , [ 57] ;
McCutcheon et al., [ 36] ; Cone et al., [ 11] ), but it is unaffected in healthy animals in which corticosterone can
fluctuate naturally.
Finally, it is important to note that stress and glucocorticoids could potentiate DA responses to natural rewards
under different conditions. Many studies that observe an increase in eating due to stress or glucocorticoids
involve repeated exposures to stress, stress hormones, and calorically dense food (Dallman et al., [ 14] ;
Dallman, [ 13] ; Sominsky & Spencer, [ 47] ). This sort of experience could produce changes in how stress and
food stimuli interact neurologically based on homeostatic pressures or learned compensatory or prophylactic
behaviors (Pecoraro et al., [ 38] ; Ulrich‐Lai et al., [ 52] ; Liang et al., [ 29] ). In the present study, the exposure to
corticosterone was acute, saccharin is palatable but non‐caloric, and there was no opportunity for subjects to
learn any association between food consumption and the stress response. In other situations, glucocorticoids
can stimulate appetite through many physiological pathways (Sominsky & Spencer, [ 47] ), but the present
results suggest that the critical appetite‐inducing action of corticosterone is not likely to be a selective reduction
of DA clearance in the NAc.

Conclusion
Stress and the cascade of physiological events that it induces have a profound effect on motivated behavior. This
leaves open the possibility that stress‐induced glucocorticoid release influences DA responses to drugs of abuse
and natural rewards via a common pathway. Here, we observed that one potential mechanism, corticosterone's
impact on DA clearance, boosts the increase in extracellular DA caused by cocaine, but does not affect the DA
response to a natural reward. The results reveal a corticosterone‐sensitive DA clearance mechanism that, in

concert with the DA transporter, contributes to the regulation of dopaminergic neurotransmission in the NAc
and may underlie stress and glucocorticoid influences on cocaine‐seeking behavior.
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Graph: Average colorplots depict the dopamine response to corticosterone and cocaine. Blue arrows show the
treatments during the three experimental phases. Colorplots depict cyclic voltammetric data during an average
of the 30‐s bins during each experimental phase for representative rats from each group. The ordinate is the
applied voltage, and the abscissa is time. Changes in current detected by the carbon fiber electrode are
indicated in color. [Colour figure can be viewed at wileyonlinelibrary.com ].
Graph: Corticosterone augments the response to cocaine in the NA c core and shell. (A) Mean time‐averaged DA
concentrations of corticosterone‐injected subjects in each the recording subregion (shell or core). Open circles
show means for individual subjects. There was no significant difference between the two subregions ( P
s > 0.40). (B) Mean time‐averaged DA concentrations during the different phases of the experiment for vehicle
and corticosterone (Cort) injected subjects. Asterisk indicate significant differences ( P s <.05). DA concentrations
were elevated after corticosterone (2 mg/kg, i.p.) administration ( P < 0.007), and further elevated after an
injection of low‐dose cocaine (2.5 mg/kg i.p.; P < 0.001). (C) Electrode placements for vehicle‐ (gray) and
corticosterone (black)‐treated subjects in the core (Xs) and shell (Os) of the NA c. [Colour figure can be viewed at
wileyonlinelibrary.com ].
Graph: Corticosterone selectively affects uptake‐sensitive characteristics of DA transients. (A) The colorplot (left)
depicts DA transients in one subject. The white arrows identify six transients that occurred over 20 s. The line
graph (right) isolates the current at DA 's oxidation potential and depicts the uptake‐sensitive measures of
spontaneous DA transients (amplitude and half‐width). (B) Means showing the average transient amplitude ( nM
) during the different phases of the experiment for vehicle‐ and corticosterone (Cort)‐injected subjects. Open
circles show data for individual subjects. Asterisk indicate significant differences ( P s <.05). Transient amplitude
increased after corticosterone administration ( P < 0.007), and increased further after cocaine administration (
P < 0.005). (C) Average transient half‐width (ms). Half‐width increased after corticosterone administration (
P < 0.001), and increased further after cocaine administration ( P < 0.001). Cocaine did have an effect on half‐
width after vehicle administration ( P < 0.03), but the effect of cocaine was larger when administered after
corticosterone ( P < 0.001). (D) Average transient frequency (counts/min). Transient frequency was unaffected
by vehicle, corticosterone, and cocaine administration, indicating that corticosterone and cocaine selectively
affected DA clearance ( P s > 0.07). [Colour figure can be viewed at wileyonlinelibrary.com ].
Graph: Corticosterone does not affect the DA response to an appetitive taste. (A) The timing of events in the
saccharin experiment. Thirty 15‐s saccharin infusions (red tick‐marks) were administered during the pre‐ and
post‐corticosterone saccharin phases. (B) An average colorplot for a representative rat showing the DA response
to the saccharin infusions (horizontal red bar). (C) Means (± SEM ) of the average change in DA concentration
during saccharin infusion before (black) and after (blue) corticosterone administration. (D) Means of the average
change in DA concentration during the baseline and saccharin epochs. Open circles show means for individual
subjects. Saccharin increased DA concentration ( P < 0.02), but this effect was unaltered by corticosterone
administration ( P s > 0.77). (E) Electrode placements. [Colour figure can be viewed at wileyonlinelibrary.com ].
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Fig. 1. Average colorplots depict the dopamine response to corticosterone and cocaine. Blue arrows show the
treatments during the three experimental phases. Colorplots depict cyclic voltammetric data during an average
of the 30-s bins during each experimental phase for representative rats from each group. The ordinate is the
applied voltage, and the abscissa is time. Changes in current detected by the carbon fiber electrode are
indicated in color. [Colour figure can be viewed at wileyonlinelibrary.com].

Fig. 2. Corticosterone augments the response to cocaine in the NAc core and shell. (A) Mean time-averaged DA
concentrations of corticosterone-injected subjects in each the recording subregion (shell or core). Open circles
show means for individual subjects. There was no significant difference between the two subregions (Ps > 0.40).
(B) Mean time-averaged DA concentrations during the different phases of the experiment for vehicle and
corticosterone (Cort) injected subjects. Asterisk indicate significant differences (Ps < .05). DA concentrations

were elevated after corticosterone (2 mg/kg, i.p.) administration (P < 0.007), and further elevated after an
injection of low-dose cocaine (2.5 mg/kg i.p.; P < 0.001). (C) Electrode placements for vehicle- (gray) and
corticosterone (black)- treated subjects in the core (Xs) and shell (Os) of the NAc. [Colour figure can be viewed at
wileyonlinelibrary.com].

Fig. 3. Corticosterone selectively affects uptake-sensitive characteristics of DA transients. (A) The colorplot (left)
depicts DA transients in one subject. The white arrows identify six transients that occurred over 20 s. The line
graph (right) isolates the current at DA’s oxidation potential and depicts the uptake-sensitive measures of
spontaneous DA transients (amplitude and half-width). (B) Means showing the average transient amplitude (nM)
during the different phases of the experiment for vehicle- and corticosterone (Cort)-injected subjects. Open
circles show data for individual subjects. Asterisk indicate significant differences (Ps < .05). Transient amplitude
increased after corticosterone administration (P < 0.007), and increased further after cocaine administration (P <
0.005). (C) Average transient half-width (ms). Half-width increased after corticosterone administration (P <
0.001), and increased further after cocaine administration (P < 0.001). Cocaine did have an effect on half-width
after vehicle administration (P < 0.03), but the effect of cocaine was larger when administered after
corticosterone (P < 0.001). (D) Average transient frequency (counts/min). Transient frequency was unaffected by
vehicle, corticosterone, and cocaine administration, indicating that corticosterone and cocaine selectively
affected DA clearance (Ps > 0.07). [Colour figure can be viewed at wileyonlinelibrary.com].

Fig. 4. Corticosterone does not affect the DA response to an appetitive taste. (A) The timing of events in the
saccharin experiment. Thirty 15-s saccharin infusions (red tick-marks) were administered during the pre- and
post-corticosterone saccharin phases. (B) An average colorplot for a representative rat showing the DA response
to the saccharin infusions (horizontal red bar). (C) Means ( SEM) of the average change in DA concentration
during saccharin infusion before (black) and after (blue) corticosterone administration. (D) Means of the average
change in DA concentration during the baseline and saccharin epochs. Open circles show means for individual
subjects. Saccharin increased DA concentration (P < 0.02), but this effect was unaltered by corticosterone
administration (Ps > 0.77). (E) Electrode placements. [Colour figure can be viewed at wileyonlinelibrary.com].

